patent/CL-2010000845-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52086740f302f427f4df239ef8a1ccb http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d55106562b394754d147396606e8ad51
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19
filingDate	2010-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f85443cb435686600e899ebf72e836c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f382bcfaac369539b221e6eacf44968a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_862bf48f1e2ad9943bd2a011ad0f6d22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3336ee9d69b59334c159b1882898f742
publicationDate	2010-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	CL-2010000845-A1
titleOfInvention	Use of maslinic acid or its derivatives to prepare a useful medicine in the treatment of pathologies that occur with the activation of cox-2.
abstract	Use of maslinic acid or any of its derivatives for the treatment of pathologies that occur with the activation of cox-2, osteoarthritis, rheumatoid arthritis, fibromyalgia, among others; pharmaceutical composition
priorityDate	2010-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73659 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7163260 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426392440 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419517435

Total number of triples: 20.